FIELD: medicine; therapy.
SUBSTANCE: group of inventions relates to the field of medicine, namely to therapy; it is intended for the use in prevention or treatment of constipation. A heterocyclic compound of the formula (I) is presented, as well as following heterocyclic compounds: N-((3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl)-7-(4-(1-methyl-1H-1,2,3-triazole-4-yl)benzyl)-2,3-dihydrofuro[3,2-b]pyridine-5-carboxamide, 7-(3-fluor-4-((2-methoxyethyl)carbamoyl)benzyl)-N-((3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl)-2,3-dihydrofuro[3,2-b]pyridine-5-carboxamide, 7-(3-fluor-4-((((S)-tetrahydrofuran-2-yl)methyl)carbamoyl)benzyl)-N-((3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl)-2,3-dihydrofuro[3,2-b]pyridine-5-carboxamide. In another embodiment, drugs containing these compounds are provided. A method for positive allosteric modulation of a cholinergic muscarinic M1 receptor, a method for prevention or treatment of constipation, using these compounds, and the use of the specified compounds for the production of a preventive or therapeutic drug for constipation are also provided.
EFFECT: group of inventions provides new heterocyclic compounds characterized by positive allosteric modulating activity relatively to cholinergic muscarinic M1 receptor and used as a drug, such as a preventive or therapeutic drug for constipation.
16 cl, 6 tbl, 113 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC COMPOUND | 2019 |
|
RU2806347C2 |
DERIVATIVES OF 2-AMINOPYRIDINE OR 2-AMINOPYRIMIDINE AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2019 |
|
RU2762557C1 |
CONDENSED HETEROCYCLIC COMPOUND | 2005 |
|
RU2389731C2 |
2-AMINOPYRIDINE OR 2-AMINOPYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2019 |
|
RU2790006C2 |
2-THIOSUBSTITUTED CARBAPENEMS, INTERMEDIATE COMPOUNDS FOR SYNTHESIS, METHODS OF SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130457C1 |
BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2012 |
|
RU2662827C2 |
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
PYRIDINONE PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | 2007 |
|
RU2472782C2 |
Authors
Dates
2023-03-09—Published
2018-06-19—Filed